Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer.
Savin Z, Mano R, Lazarovich A, Rosenzweig B, Shashar R, Hoffman A, Pilosov I, Freifeld Y, Shpitzer SA, Golan S, Yossepowitch O, Sofer M. Savin Z, et al. Among authors: freifeld y. Clin Genitourin Cancer. 2024 Apr;22(2):491-496. doi: 10.1016/j.clgc.2024.01.004. Epub 2024 Jan 6. Clin Genitourin Cancer. 2024. PMID: 38267303
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410".
Rosenzweig B, Haramaty R, Davidson T, Lazarovich A, Shvero A, Haifler M, Gal J, Golan S, Shpitzer S, Hoffman A, Nativ O, Freifeld Y, Zreik R, Dotan ZA. Rosenzweig B, et al. Among authors: freifeld y. J Pers Med. 2022 May 25;12(6):861. doi: 10.3390/jpm12060861. J Pers Med. 2022. PMID: 35743645 Free PMC article.
Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes.
Herzberg H, Lifshitz K, Golan S, Baniel J, Malshy K, Hoffman A, Amiel GE, Zreik R, Freifeld Y, Dekel Y, Lasmanovich R, Lazarovich A, Rosenzweig B, Dotan Z, Yossepowitch O, Mano R. Herzberg H, et al. Among authors: freifeld y. BJU Int. 2022 Oct;130(4):470-477. doi: 10.1111/bju.15757. Epub 2022 May 17. BJU Int. 2022. PMID: 35476895 Free PMC article.
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus.
Freifeld Y, Pedrosa I, Mclaughlin M, Correa RM, Louie AV, Maldonado JA, Tang C, Kadow B, Kutikov A, Uzzo RG, Porta C, Bucknell NW, Siva S, Brugarolas J, Margulis V, Timmerman R, Hannan R. Freifeld Y, et al. Urol Oncol. 2022 Apr;40(4):166.e9-166.e13. doi: 10.1016/j.urolonc.2021.12.018. Epub 2022 Feb 8. Urol Oncol. 2022. PMID: 35144866 Free PMC article.
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
Ghandour RA, Freifeld Y, Cheaib J, Singla N, Meng X, Kenigsberg A, Bagrodia A, Woldu S, Hoffman-Censits J, Enikeev D, Rapoport L, Petros FG, Raman JD, Pierorazio PM, Matin SF, Margulis V. Ghandour RA, et al. Among authors: freifeld y. Urol Oncol. 2021 Nov;39(11):788.e15-788.e21. doi: 10.1016/j.urolonc.2021.05.037. Epub 2021 Jul 28. Urol Oncol. 2021. PMID: 34330655
Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.
Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R. Margulis V, et al. Among authors: freifeld y. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1135-1142. doi: 10.1016/j.ijrobp.2021.01.054. Epub 2021 Feb 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 33549705 Free PMC article. Clinical Trial.
43 results